China Investors Rush to Exit After Crackdown on Illicit Overseas Stock Trading April Jobs Report Preview Labor Market Resilience Amid Cooling Signals Weighing the Medicare Premium Consequences of a 235000 Roth IRA Conversion US Productivity Growth Cools in Q4 as Labor Costs Rise Stirring Inflation Concerns Mistral AI Considers InHouse Chip Development to Cut Costs and Compete with US Rivals AU Real Estate Plans Rs 1200 Crore Housing Project in Ghaziabad CRSR Q1 2026 Earnings EPS Blows Past Estimates Shares Soar 22 CRGY Q1 2026 Earnings Earnings Surge Past Estimates as Operational Efficiency Drives Strong Results FCAP Q1 2026 Earnings EPS of 130 Highlights Cost Discipline Amid Modest Operating Environment Evotec Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Movement Highwoods Properties Inc HIW Q1 2026 Earnings Significant EPS Surprise Driven by Strong Operational Performance Soleno Therapeutics Q1 2026 Earnings EPS Misses Estimates by 1494 Stock Holds Steady Invesco Pennsylvania Value Municipal Income Trust VPV Edges Higher Testing Key Levels Empire Petroleum EP Surges 776 as Momentum Builds Above Key Support Melar Acquisition Corp I Warrant MACIW Holds Near Support Amidst Low Volume Trading Silo Pharma Inc SILO Holds Above 040 Support After Modest Gains Forum Energy Technologies FET Slides Nearly 4 Support Levels in Focus China Investors Shift Funds After Crackdown on Overseas Stock Trading CW Q1 2026 Earnings EPS Surpasses Estimates Stock Edges Higher Eureka Acquisition Corp EURK Trading in a Tight Range Near 115 Support and Resistance Levels in Focus Robinhood Unveils AI Agents for Automated Trading and Spending The AI Economy Reshapes the American Dream BlueCollar Workers Emerge as Key Winners Billionaire Vincent Bollors Media Grip Raises Concerns EU Fund Proposed to Safeguard Democracy Companies Double Down on Prediction Market Investments Amid Regulatory Uncertainty Carney Warns Alberta Separatists of BrexitStyle Economic Regret Spain Blocks Polymarket and Kalshi Over Gambling License Requirements Eli Lilly Expands Vaccine Portfolio with Up to 38 Billion in Deals for Three Developers